• 847 Citations
  • 15 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Valesca Pavlawna Retèl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 59 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Biomedical Technology Assessment Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences
Genes Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

1 Citation (Scopus)
3 Downloads (Pure)

Impact of organ-on-a-chip technology on pharmaceutical R&D costs

Franzen, N., van Harten, W. H., Retèl, V. P., Loskill, P., van den Eijnden-van Raaij, J. & IJzerman, M., 8 Jun 2019, In : Drug discovery today.

Research output: Contribution to journalShort surveyAcademicpeer-review

Open Access
Pharmaceutical Technology
Costs and Cost Analysis
Drug Costs
Drug Discovery
5 Downloads (Pure)

Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician's prescription and reimbursement in eight European countries

Beck, A. C. C., Retèl, V. P., van den Brekel, M. W. M. & van Harten, W. H., 1 Apr 2019, In : Oral Oncology. 91, p. 56-64 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
Artificial Larynges
Hot Temperature
Equipment and Supplies
1 Downloads (Pure)
Open Access
Cancer Care Facilities
Non-Small Cell Lung Carcinoma
Molecular Pathology
1 Downloads (Pure)

(Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: Design of the PABLO trial 11 Medical and Health Sciences 1117 Public Health and Health Services

Van De Wiel, H. J., Stuiver, M. M., May, A. M., Van Grinsven, S., Aaronson, N. K., Retèl, V. P., Oldenburg, H. S. A., Van Der Poel, H. G., Horenblas, S., Van Harten, W. H. & Groen, W. G., 6 Nov 2018, In : BMC cancer. 18, 1, 1073.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
Health Services
Cost-Benefit Analysis
1 Citation (Scopus)
17 Downloads (Pure)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation

Retel, V. P., Steuten, L. M. G., Foppen, M. H. G., Mewes, J. C., Lindenberg, M. A., Haanen, J. B. A. G. & van Harten, W. H., 15 Sep 2018, In : BMC cancer. 18, 1, 895.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access